Carcinogenesis, Vol. 21, No. 10, 1809-1812,
October 2000
© 2000 Oxford University Press
Cancer Biology |
Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels
Anatomy Department and
1 Pharmacology Department, National University of Singapore, Kent Ridge, S119260,
2 Pathology Department, Tan Tock Seng Hospital, Moulmein Road, S308433,
3 Otolaryngology Department, Singapore General Hospital, Outram Road, S169608, Singapore
Metallothionein (MT) is a cysteine-rich protein with pleiotropic functions and a high binding affinity for heavy metals. The present study was designed to examine the relationship between MT expression and tissue zinc levels in conjunction with cell proliferation in nasopharyngeal cancer (NPC). Proliferative activity in NPC was quantified by Ki67 immunolabelling and MT expression was determined by immunohistochemistry. Total zinc and subcellular zinc fractions were analysed by flame atomic absorption spectrometry. MT immunostaining was observed in the nuclei of NPC cells, with the percentage MT immunopositivity ranging from 3.0 to 59.7%. Thirteen tumours displayed weak MT staining and the remaining 11 showed moderate to strong immunostaining. There was a significant positive correlation between MT and Ki67 positivity (P = 0.0127). Tissue zinc levels were higher in NPC as compared with benign nasopharyngeal tissues (4.800 ± 0.4610 versus 2.889 ± 0.4045 µg/g dry wt tissue, respectively; P = 0.0122). Nuclear zinc levels in NPC were significantly higher than levels in membrane and cytosolic fractions (mean zinc levels 1.4840 ± 0.1489, 0.6286 ± 0.0789 and 0.3014 ± 0.0250 µg/mg protein, respectively). A linear relationship was also observed between nuclear zinc levels and MT immunostaining (P = 0.0024) as well as with Ki67 immunopositivity (P = 0.0123). Our results show that MT and zinc are correlated with proliferative activity in NPC, providing further insights into the biology of this enigmatic and aggressive tumour.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. SZELACHOWSKA, P. DZIEGIEL, J. JELEN-KRZESZEWSKA, M. JELEN, R. TARKOWSKI, B. SPYTKOWSKA, R. MATKOWSKI, and J. KORNAFEL Correlation of Metallothionein Expression with Clinical Progression of Cancer in the Oral Cavity Anticancer Res, February 1, 2009; 29(2): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-H. Bay, R. Jin, J. Huang, and P.-H. Tan Metallothionein as a prognostic biomarker in breast cancer. Experimental Biology and Medicine, October 1, 2006; 231(9): 1516 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Magda, P. Lecane, R. A. Miller, C. Lepp, D. Miles, M. Mesfin, J. E. Biaglow, V. V. Ho, D. Chawannakul, S. Nagpal, et al. Motexafin Gadolinium Disrupts Zinc Metabolism in Human Cancer Cell Lines Cancer Res., May 1, 2005; 65(9): 3837 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Tai, O. J.-K. Tan, V. T.-K. Chow, R. Jin, J. L. Jones, P.-H. Tan, A. Jayasurya, and B.-H. Bay Differential Expression of Metallothionein 1 and 2 Isoforms in Breast Cancer Lines with Different Invasive Potential: Identification of a Novel Nonsilent Metallothionein-1H Mutant Variant Am. J. Pathol., November 1, 2003; 163(5): 2009 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jayasurya, W.-M. Yap, N.-G. Tan, B. K.-H. Tan, and B.-H. Bay Glutathione S-Transferase {pi} Expression in Nasopharyngeal Cancer Arch Otolaryngol Head Neck Surg, December 1, 2002; 128(12): 1396 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jin, V. T.-K. Chow, P.-H. Tan, S.T. Dheen, W. Duan, and B.-H. Bay Metallothionein 2A expression is associated with cell proliferation in breast cancer Carcinogenesis, January 1, 2002; 23(1): 81 - 86. [Abstract] [Full Text] [PDF]
|
|